Background: Although endoscopic hemostasis is standard of care in NVUGIH, there is still uncertainty about what defines “best practice” in various clinical circumstances. Three areas, in particular, have been the subject of debate and practice variation: (1) snaring adherent ulcer clots, (2) use of hemoclips in active bleeding, and (3) monotherapy vs. dual therapy in active bleeding. We conducted a national vignette survey to measure current practice patterns in these 3 areas in a group of experts and “non-expert” community providers. Methods: We developed an online survey that included clinical vignettes of patients with NVUGIH. The vignettes were developed with a panel of content experts to ensure face validity and comprehensiveness. In each vignette, respondents first viewed a standardized patient presentation, and then received management questions guided by branching conditional logic. Upon EGD, respondents viewed an image of an actively “spurting” vessel in one vignette, and an adherent clot in another vignette. The survey elicited provider knowledge and beliefs about various aspects of NVUGIH care, including use of endoscopic hemostasis. We surveyed a random sample of 360 GIs from the AGA membership rolls, and 40 internationally recognized NVUGIH experts. Results: 47% responded (N = 188; 25 experts). In the adherent clot vignette, 88% of experts opted to snare the clot and treat the underlying stigmata, whereas 56% of “non experts” endorsed this method (group Δ = 26%; 95% CI of Δ = 11-52%; p = 0.02). In multivariable regression adjusting for provider demographics, practice setting, and experience, experts were 6 times more likely to snare vs. non-experts (OR = 5.99; 1.6-22.3; p = 0.001). Among the 15% of respondents who did not correctly identify the image as a clot (N = 23), 48% used epi + heater probe injection, while the rest used one of 7 alternatives. In the “spurting vessel” vignette, 33% of respondents used a hemoclip, either alone (7%) or with epi (27%). 87% of respondents used dual therapy (60% epi + probe, 27% epi + clip). Of those using monotherapy, most endorsed using clip alone. Expert vs. non-expert for hemoclip and dual therapy = NS. Conclusions: (1) Experts are much more likely than “non experts” to snare an overlying clot, suggesting a relative lack of buy-in, familiarity, or comfort of community GIs with this technique. (2) Use of clip is gaining traction, although <50% of experts and non-experts prefer it over alternatives, suggesting that further research is necessary to clarify its role. (3) Most providers use dual therapy, although a notable minority prefers clip monotherapy - a strategy deserving further research.